Literature DB >> 27440671

Histological analysis and gene expression profile following augmentation of the anterior maxilla using rhBMP-2/ACS versus autogenous bone graft.

Rubens Moreno de Freitas1, Cristiano Susin2,3, Wirla Maria da Silva Cunha Tamashiro4, João Antonio Chaves de Souza5, Claudio Marcantonio6, Ulf Me Wikesjö2,3, Luís Antônio Violin Dias Pereira7, Elcio Marcantonio6.   

Abstract

AIM: The objective of this report was to present histological characteristics and gene expression profile of newly formed bone following horizontal augmentation of the atrophic anterior maxilla using recombinant human bone morphogenetic protein-2 in an absorbable collagen sponge carrier (rhBMP-2/ACS) versus an autogenous bone graft (ABG).
METHODS: Bone core biopsies from 24 subjects participating in a randomized clinical trial were obtained at dental implant placement, 6 months following alveolar ridge augmentation using rhBMP-2/ACS (rhBMP-2 at 1.5 mg/ml; total dose 4.2 mg) or a particulate ABG harvested from the mandibular retro-molar region. A titanium mesh was used to provide wound stability and space for bone formation. Analysis included histological/histometric observations and gene expression profile of the newly formed bone.
RESULTS: rhBMP-2/ACS yielded bone marrow rich in capillaries, undifferentiated cells and bone lining cells compared with the ABG (p = 0.002). Whereas no significant differences were observed in total bone fraction (p = 0.53), non-vital bone particles trapped in lamellar vital bone were observed in the ABG group (p < 0.001). Real-time PCR showed greater BMP-2 and RUNX2 expression for rhBMP-2/ACS over the ABG (p = 0.001 and 0.0021, respectively), while the ABG exhibited greater expression of RANKL:OPG, BSP and OPN over rhBMP-2/ACS (p = 0.01, 0.005 and 0.0009, respectively).
CONCLUSIONS: Our observations suggest that formative biological processes explain bone formation following implantation of rhBMP-2/ACS, whereas remodelling, resorptive/formative processes, characterizes sites receiving ABGs.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  alveolar ridge augmentation; autogenous bone graft; randomized controlled trial; recombinant human bone morphogenetic protein; rhBMP-2

Mesh:

Substances:

Year:  2016        PMID: 27440671     DOI: 10.1111/jcpe.12601

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  4 in total

1.  Enhanced bone formation of calvarial bone defects by low-intensity pulsed ultrasound and recombinant human bone morphogenetic protein-9: a preliminary experimental study in rats.

Authors:  Takatomo Imafuji; Yoshinori Shirakata; Yukiya Shinohara; Toshiaki Nakamura; Kazuyuki Noguchi
Journal:  Clin Oral Investig       Date:  2021-03-23       Impact factor: 3.606

2.  Comparison of Bone Regeneration in Different Forms of Bovine Bone Scaffolds with Recombinant Human Bone Morphogenetic Protein-2.

Authors:  Hyun Seok; Hee-Youl Kim; Dong-Cheol Kang; Jung-Ho Park; Jong Hoon Park
Journal:  Int J Mol Sci       Date:  2021-10-15       Impact factor: 5.923

3.  Human bone morphogenetic protein-2 (hBMP-2) characterization by physical-chemical, immunological and biological assays.

Authors:  Miriam Fussae Suzuki; João Ezequiel Oliveira; Renata Damiani; Eliana Rosa Lima; Kleicy Cavalcante Amaral; Anderson Maikon de Souza Santos; Geraldo Santana Magalhães; Leonardo Perez Faverani; Luis Antonio Violin Dias Pereira; Fabiana Medeiros Silva; Paolo Bartolini
Journal:  AMB Express       Date:  2020-02-17       Impact factor: 3.298

4.  Synthesis of Human Bone Morphogenetic Protein-2 (hBMP-2) in E. coli Periplasmic Space: Its Characterization and Preclinical Testing.

Authors:  João E Oliveira; Miriam F Suzuki; Renata Damiani; Eliana R Lima; Kleicy C Amaral; Anderson M S Santos; Geraldo S Magalhães; Leonardo P Faverani; Luís A V D Pereira; Paolo Bartolini
Journal:  Cells       Date:  2021-12-14       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.